Drugs / DuoTrav
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | DuoTrav | — | 2006-04-23 | europa.eu ↗ |
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT01696383 | Feb 2013 | glaucoma, ocular hypertension | Alcon Research | Withdrawn | No outcome recorded |
| Phase 4 | NCT00828906 | Feb → Nov 2009 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01542710 | Jan → Dec 2011 | open-angle glaucoma | Kasr El Aini Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00862472 Comparator | Mar → Jun 2009 | ocular hypertension, open-angle glaucoma | Alcon Research | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DuoTrav | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00862472 ↗ |
| Route | Topical | “DuoTrav Eye Drops” NCT00828906 ↗ |